# § 522.1338   Medetomidine and vatinoxan.

(a) *Specifications.* Each milliliter of solution contains 0.5 milligrams (mg) medetomidine hydrochloride and 10 mg vatinoxan hydrochloride.


(b) *Sponsor.* See No. 043264 in § 510.600(c) of this chapter.


(c) *Conditions of use*—(1) *Amount.* Administer by intramuscular injection a dose based on body surface area (BSA). Calculate the dose using 1 mg medetomidine per square meter (/m
2) BSA or use the dosing table provided in labeling.


(2) *Indications for use.* For use as a sedative and analgesic in dogs to facilitate clinical examination, clinical procedures, and minor surgical procedures.


(3) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.



---

[N] [87 FR 58962, Sept. 29, 2022, as amended at 87 FR 76421, Dec. 14, 2022]




